Spectrofluorimetric Method for Determination of Bupropion in Pharmaceutical Dosage Forms; [Methode De Determination Spectrofluorimetrique Du Bupropion Dans Les Formulations Pharmaceutiques]

Spectrofluorimetric Method for Determination of Bupropion in Pharmaceutical Dosage Forms; [Methode De Determination Spectrofluorimetrique Du Bupropion Dans Les Formulations Pharmaceutiques] Publisher Pubmed

Souri E¹ ; Rahmatpoor S¹ ; Barazandeh Tehrani M¹

Show Affiliations

1. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 14155-6451, Iran

Source: Annales Pharmaceutiques Francaises Published:2019

Abstract

Objective: Bupropion is a noradrenaline and dopamine reuptake inhibitor which is used as an antidepressant drug. Few HPLC and spectrophotometric methods have been reported before for the determination of bupropion. Most of the previous methods reported for determination of bupropion in pharmaceutical dosage forms are somehow dangerous to health and environment because of using organic solvents. Method: In the present method bupropion was determined in pharmaceutical dosage forms by spectrofluorimetry after ion-pair complex formation with eosin Y. The ion-pair complex formation was optimized for reagent amount, buffer pH and time. Result: The developed method was linear over the range of 3–120 μg mL−1 with an acceptable precision (CV < 1.5%) and accuracy (Error < 1%). Conclusion: The present method is applicable for determination of bupropion in pharmaceutical dosage forms for routine quality control analysis. © 2019

Style	Citing Format
MLA	Souri E, Rahmatpoor S, Barazandeh Tehrani M. "Spectrofluorimetric Method for Determination of Bupropion in Pharmaceutical Dosage Forms; [Methode De Determination Spectrofluorimetrique Du Bupropion Dans Les Formulations Pharmaceutiques]." Annales Pharmaceutiques Francaises, vol. 77, no. 6, 2019, pp. 460-467.
APA	Souri E, Rahmatpoor S, Barazandeh Tehrani M (2019). Spectrofluorimetric Method for Determination of Bupropion in Pharmaceutical Dosage Forms; [Methode De Determination Spectrofluorimetrique Du Bupropion Dans Les Formulations Pharmaceutiques]. Annales Pharmaceutiques Francaises, 77(6), 460-467.
Chicago	Souri E, Rahmatpoor S, Barazandeh Tehrani M. "Spectrofluorimetric Method for Determination of Bupropion in Pharmaceutical Dosage Forms; [Methode De Determination Spectrofluorimetrique Du Bupropion Dans Les Formulations Pharmaceutiques]." Annales Pharmaceutiques Francaises 77, no. 6 (2019): 460-467.
Harvard	Souri E, Rahmatpoor S, Barazandeh Tehrani M (2019) 'Spectrofluorimetric Method for Determination of Bupropion in Pharmaceutical Dosage Forms; [Methode De Determination Spectrofluorimetrique Du Bupropion Dans Les Formulations Pharmaceutiques]', Annales Pharmaceutiques Francaises, 77(6), pp. 460-467.
Vancouver	Souri E, Rahmatpoor S, Barazandeh Tehrani M. Spectrofluorimetric Method for Determination of Bupropion in Pharmaceutical Dosage Forms; [Methode De Determination Spectrofluorimetrique Du Bupropion Dans Les Formulations Pharmaceutiques]. Annales Pharmaceutiques Francaises. 2019;77(6):460-467.
BibTex	@article{ author = {Souri E and Rahmatpoor S and Barazandeh Tehrani M}, title = {Spectrofluorimetric Method for Determination of Bupropion in Pharmaceutical Dosage Forms; [Methode De Determination Spectrofluorimetrique Du Bupropion Dans Les Formulations Pharmaceutiques]}, journal = {Annales Pharmaceutiques Francaises}, volume = {77}, number = {6}, pages = {460-467}, year = {2019} }
RIS	TY - JOUR AU - Souri E AU - Rahmatpoor S AU - Barazandeh Tehrani M TI - Spectrofluorimetric Method for Determination of Bupropion in Pharmaceutical Dosage Forms; [Methode De Determination Spectrofluorimetrique Du Bupropion Dans Les Formulations Pharmaceutiques] JO - Annales Pharmaceutiques Francaises VL - 77 IS - 6 SP - 460 EP - 467 PY - 2019 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract